🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06060886
Treatments Being Tested
The purpose of this trial is to investigate the efficacy of risperidone as ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2004-06
Trial ID
NCT00167154
Treatments Being Tested
An inpatient/outpatient study to see if LY2140023 is better than placebo in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-03
Trial ID
NCT01086748
Treatments Being Tested
This trial examines the efficacy of cannabidiol (CBD) versus risperidone fo...
Status
Active Not Recruiting
Location
Center for Neuropsychiatric Schizophrenia Research
Start Date
2021-06-01
Trial ID
NCT04105231
Treatments Being Tested
This 16-week placebo-control study looks to investigate whether patients wi...
Status
Completed
Location
The Zucker Hillside Hospital
Start Date
2013-05
Trial ID
NCT01786239
Treatments Being Tested
The study examines and illustrates the utility of utilizing actigraphic mea...
Status
Completed
Location
Child Psychopharmacology Institute
Start Date
2008-05
Trial ID
NCT00723580
Treatments Being Tested
The purpose of this study is to evaluate efficacy, safety and tolerance of ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT01726335
Treatments Being Tested
This study will determine the effectiveness of oral risperidone versus long...
Status
Completed
Location
Semel Institute for Neuroscience and Human Behavior at UCLA
Start Date
2006-03
Trial ID
NCT00330551
Treatments Being Tested
The purpose of this study is to test the efficacy of transcranial direct cu...
Status
Withdrawn
Location
Zucker-Hillside Hospital
Start Date
2016-02
Trial ID
NCT02661347
Treatments Being Tested